))
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
Manage episode 479033909 series 3648058
Content provided by Dr. Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.
CME information and select publications here.
56 episodes
Share
